Research
Hormonal
Medicaid patients using adjuvant GLP-1RA showed a PDC of 88.25% compared to 70.32% for SGA-only users.
GLP-1RA may significantly improve adherence among Medicaid patients on SGAs.
StrongSupportsmedium confidence
Medicaid patients showed similar benefits (PDC: 88.25% vs 70.32%)
Why this rating
Based on the retrospective cohort study design with a large sample size.
Source
Impact of Adjuvant GLP-1RA Treatment on the Adherence of Second-Generation Antipsychotics in Nondiabetic Adults
Jerusha Daggolu et al. · Journal of Clinical Psychopharmacology · 2026
cohort · n=2940
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →